FreeStyle Libre 2 logo

Continuous glucose monitoring is transforming diabetes management1

Deliver more value to patients and payers with the FreeStyle Libre 2 system*2,*3,4,5

Download Brochure

FreeStyle Libre 2 CGM System

Do you want to start offering your customers CGM?

Fill out the form on the right to get in touch with a Milliken Medical sales representative today.

Man scanning FreeStyle Libre 2 sensor with phone

Take advantage of your opportunity to participate in the growth of the CGM market and begin offering your customers the FreeStyle Libre

Large and growing market: 28.7 million Americans are diagnosed with diabetes6, and 8.5 million people remain undiagnosed6

Reimbursement friendly: the FreeStyle Libre CGM System is covered by Medicare** and most commercial insurance plans7 as a Medical Benefit

Recurring revenue stream: CGM sensors are ordered monthly or quarterly

Improve diabetes care: allow your customers to better manage their glucose levels and make more informed healthcare decisions

The FreeStyle Libre 2 system helps patients and provides make informed diabetes management decisions with unsurpassed 14 day accuracy8

Painless: Check glucose with a painless†◊ scan instead of fingersticks***

Easy: Easy iCGM to apply with no in-person patients training required7

Actionable: Real-time alarms§ that notify patients the minute their glucose is too low or too high

Woman checking her phone while gardening

The FreeStyle Libre 2 system is covered by Medicare** and most commercial insurance plans7 as a medical benefit

FreeStyle Libre 2 CGM System
CGM Infographic

How CGM Works

CGM systems contain two elements:

The sensor: CGM sensors are small devices applied to the back of the upper arm. Sensors contain a flexible tip that is inserted just under the skin. They continuously measure and store glucose readings.

The monitor: CGM monitors are used to read and interpret the blood glucose measurements collected by the sensor. Because the sensor is continuously monitoring blood glucose levels, CGM monitors can show where a user’s blood glucose was, where it currently is, and where it may be headed.#

Person scanning senor with phone
Man checking FreeStyle Libre 2 app at kitchen table

Benefits of CGM

CGM systems, like FreeStyle Libre, give real-time glucose readings to help users manage their diabetes more carefully. Some benefits of CGM systems:

  • Painless scans that don’t require fingersticks
  • Tracking glucose levels and patterns over time#
  • Quick monitoring process that doesn’t require a finger prick

FreeStyle Libre 2 at Milliken Medical

Click on the button below to get access to professional pricing on FreeStyle Libre 2 CGM system products. Milliken Medical offers fast shipping and best-in-class customer service on FreeStyle Libre 2 products.

 

Learn More About FreeStyle Libre Products

Abbott Continuous Glucose Monitoring Brochure

Abbott CGM Brochure

Download Now

FreeStyle Libre Comparison Graphic

FreeStyle Libre Comparison Guide

Download Now

FreeStyle Libre 2 Getting Started Guide

FreeStyle Libre 2 Get Started Guide

Download Now

FreeStyle Libre Sensor Application

Sensor Application Instructions

Download Now

Market FreeStyle Libre 3 to Your Customers

Fill out the form below to get free marketing materials to provide your customers.

(1.) Bergenstal, R. The Lancet (2018): https://doi.org/10.1016/s0140-6736(18)30290-3. (2.) Guerci, B. Diabetes Technology and Therapeutics (2023): https://doi.org/10.1089/dia.2022.0271. (3.) Deshmukh, H. Diabetes Care (2020): https://doi.org/10.2337/dc20-0738. (4.) Bergenstal, R. Journal of the Endocrine Society (2021): https://doi.org/10.1210/jendso/bvab013. (5.) Frank J. Diabetes Technology and Therapeutics (2021): https://doi.org/10.1089/dia.2021.0263. (6.) CDC: National Diabetes Statistics Report. https://www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed March 2023. (7.) Data of file. Abbott Diabetes Care. (8.) FreeStyle Libre 2 User Manual. (9.) Press Release: American Diabetes Association Announces Support for INSULIN Act at Senate Press Conference. https://diabetes.org/newsroom/press-releases/2022/american-diabetes-association-announces-support-for-insulin-act-at-senate-press-conference. Accessed March 2023. (10.) CMS: Part D Senior Savings Model. https://innovation.cms.gov/innovation-models/part-d-savings-model. Accessed March 2023. (11.) The Diabetes Forum: SeaTRAK Monitor Q4 2022.

*Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional real-time glucose alarms. Therefore the study data is applicable to both products. **Medicare coverage is available for the FreeStyle Libre 2 system if the FreeStyle Libre 2 reader is used to review glucose data on some days every month. Medicare and other third party payor criteria apply. Patients must meet Medicare eligibility coverage criteria: Local Coverage Determination, Glucose Monitors (L33822). Abbott provides this information as a courtesy, it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors. ***Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.

Haak, T. Diabetes Therapy (2017): https://doi.org/10.1007/s13300-016-0223-6. Data from this study was collected with the outside US version of the FreeStyle Libre 14-day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14-day system with optional real-time glucose alarms. Therefore, the study data is applicable to both products. Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.

#Unger, Jeff, Pamela Kushner, and John E. Anderson. “Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care.” Postgraduate Medicine 132, no 4. (2020): 305-313.

Data based on the number of patients assigned to each manufacturer based on last filled prescription in US Retail Pharmacy and DME.

Based on a comparison to Dexcom G6.

§ Notifications will only be received when alarms are turned on and the sensor is within 20 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 2 User’s Manual for more information.